Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ADAC is doing amazing!!
The TRUTH IS: Undiagnosed Cardiovascular Disease Is a Killer
• 1 in 3 deaths annually are caused by heart disease
and stroke.
• 1.5 million people suffer heart attacks annually in
the U.S.
• Nearly 1/3 of the deaths could be prevented
through proactive changes in lifestyle habits.
• Often the FIRST SYMPTOM of coronary artery
disease is a heart attack.
LXGTF Article by Jonathan Maltz, "What is Endothelial Function..." : https://lexingtonbiosciences.com/news/endothelial-function-important-health/
LXGTF Corporate Presentation: https://lexingtonbiosciences.com/wp-content/uploads/2017/10/Lexington-Website-Presentation.pdf
MUST WATCH LXGTF video: https://vimeo.com/183611304
NEW HERE? Start your dd from LXGTF website: https://lexingtonbiosciences.com/
floating in green week
Good morning my dear LXGTF friends!
yes, what you think Pac?
green week... love it
have to understand why there is in need so much time to break the resistance but ok is coming
still green, entering in fine closure, accumulation coming to the right point of breaaaaking
SHORT SUMMARY LXGTF : Lexington BioSciences (CSE: LNB) (OTCQB: LXGTF) is developing
the HeartSentry, a new non-invasive diagnostic tool for accurately measuring
and monitoring cardiovascular health.
• The HeartSentry measures the function of the endothelium – the critical inner
lining of a person’s cardiovascular system.
• The core research and IP portfolio has been exclusively licensed to the
company.
• Lexington is in final stages of releasing the product into clinical studies for FDA
approval.
• The cardiovascular diagnostic market is growing fast and evolving into
personalized medicine.
• The goal is to make HeartSentry the standard of care for cardiologists, general
practitioners, and ultimately patients first line evaluation of cardiovascular
health.
• We seek the participation of dedicated stakeholders and committed
partners who share our vision of the future of cardiovascular personalized
medicine.
LXGTF simplify and save lifes! Current Standards are Complicated and Expensive
• Gold standard - ULTRASOUND
• Measurement directly views arterial diameter
changes
• Only at specialized diagnostic centers
• Requires trained ultrasonographer
• Expensive capital equipment needed
• Alternative method - ENDOPAT
• Measurement uses a fingertip blood oxygen
sensor and laptop computer.
• Only at specialized diagnostic centers
• Requires trained technician
Currently only used in specialized research centers by highly trained staff
The FACTS ARE: Undiagnosed Cardiovascular Disease Is a Killer
• 1 in 3 deaths annually are caused by heart disease
and stroke.
• 1.5 million people suffer heart attacks annually in
the U.S.
• Nearly 1/3 of the deaths could be prevented
through proactive changes in lifestyle habits.
• Often the FIRST SYMPTOM of coronary artery
disease is a heart attack.
the only solution for the problem no.1 !!
Lovely green +1,6% before Power Hour
LXGTF is pleased to announce receipt of the first HeartSentry human-use units from its manufacturer. http://techstockinsider.com/lexington-biosciences-lxgtf-receives-heartsentry-trial-units/
LXGTF Mission Statement and Values:
Quote:
________________________________________
Mission Statement
Lexington Biosciences seeks to create and promote a suite of meaningful data centered cardiovascular monitoring technologies to provide patients relevant metrics so that they can lead longer and healthier lives.
Values
Excellence. Create a challenging and dynamic environment with excellence as an achievable goal in all we do.
Progress. Our work is focused on improving the lives of others. We believe the tools to achieve a healthy society must improve and we intend to be a positive part of this ongoing evolution.
Innovate. Consistently deliver exceptional products, identify clearly unmet needs and solve them, and always seek the potential for ever better results.
Trust. Engender trust by always performing in an ethical and professional manner.
Respect. Treat our stakeholders, investors, vendors, suppliers and future customers as we would like to be treated ourselves.
LXGTF is potential 50 Billion Dollar Industry to Watch!
Read More here:
https://t.co/4nL5f2LtnQ
GOOD ARTICLE RECENTLY RELEASED
https://insiderfinancial.com/lexington-bioscien-otcmktslxgtf-venturing-into-fortune-500-territory
LXGTF engages Diablo research for next step in FDA clearance..
https://finance.yahoo.com/news/lexington-biosciences-engages-clinical-research-140000876.html
Lexington’s President Eric Willis comments, “After nine months of concerted effort by our design and production team, the arrival of our first human-use HeartSentry devices allows us to accelerate our plans to move ahead with our pilot study. Diablo Clinical Research is a proven and respected establishment with the capability to launch our research program efficiently and cost-effectively. They have been extremely helpful in the determination process which has led to today’s announcement. We are excited to begin this next step of our development phase, and look forward to sharing quantifiable results in the near future.
http://techstockinsider.com/lexington-biosciences-lxgtf-lnb-engages-clinical-research-organization/?utm_medium=Social&utm_source=TSI_Social_Link&utm_campaign=TSI_Social_1130
LOVE IT: Kovacevic continues, "An advanced Hybrid battery system can offer accelerate charging speeds, as well as higher current availability for the most demanding applications. We believe that future development of this technology could prove to have a significant impact on numerous diverse industries. Advanced hybrid storage systems are ideal but not limited to, electric vehicles, heavy equipment, emergency and portable power as well as UPS (uninterruptable power supplies) which are critical for computer systems and telecommunication equipment."
Good morning everybody!
We need mire valume here
This is huge
No copetitor in rechnology, no competitor in problem solving, no competitor in price, no competitor at all
Yesterday was one if ADAC great days and is good for us that this is not rare
Why not? Lol
Wow that sounds cool
Dr Maltz si someone you like to have on the board and not many have such a priviledge
LXGTF is awesome opportunity with no competitor in the market
This video can help any new investor here as is simly explaining complex technology and medical issues
Good morning italian, yes we breaking finaly the resistance this week I believe!
Good morning everybody! Great week.
Even the salvation is at heand but not many chose it, crazy world lol
Tnx for the link